Amgen's Leukemia Drug Gets Breakthrough Designation

Amgen said the FDA has given the breakthrough therapy designation to the company's new drug for adults with a rapidly progressing cancer of the blood and bone marrow.



from WSJ.com: US Business http://ift.tt/1mF3uzm

via IFTTT